Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
92.25
-2.10 (-2.23%)
Feb 21, 2025, 4:00 PM EST - Market closed
Blueprint Medicines Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -67.09 | -506.98 | -557.52 | -644.09 | 313.88 | Upgrade
|
| Depreciation & Amortization | 16.29 | 11.67 | 11.74 | 6.48 | 6.56 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 259.96 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -22.47 | -17.47 | -0.98 | 1.36 | 0.47 | Upgrade
|
| Stock-Based Compensation | 108.91 | 92.67 | 98.97 | 91.63 | 75.53 | Upgrade
|
| Other Operating Activities | -163.55 | 24.39 | -0.72 | 9.69 | 6.22 | Upgrade
|
| Change in Accounts Receivable | -32.7 | -7.65 | -2.23 | -11.81 | -1.85 | Upgrade
|
| Change in Inventory | -4.03 | -4.37 | -8.92 | -12.56 | -6.71 | Upgrade
|
| Change in Accounts Payable | 2.2 | 1.88 | -5.82 | 4.22 | -0.79 | Upgrade
|
| Change in Unearned Revenue | -0.41 | -12.69 | -4.81 | -4.58 | -4.92 | Upgrade
|
| Change in Other Net Operating Assets | -29.75 | -18.3 | -31.99 | 1.05 | -1.35 | Upgrade
|
| Operating Cash Flow | -192.59 | -436.85 | -502.28 | -298.65 | 387.04 | Upgrade
|
| Capital Expenditures | -4.63 | -16.06 | -8.92 | -3.09 | -3.16 | Upgrade
|
| Investment in Securities | -42.87 | 290.1 | -140.33 | 35.38 | -431.09 | Upgrade
|
| Other Investing Activities | - | - | -0.29 | -258.15 | - | Upgrade
|
| Investing Cash Flow | -47.5 | 274.04 | -149.54 | -225.86 | -434.25 | Upgrade
|
| Long-Term Debt Issued | 146.97 | 97.93 | 137.79 | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.54 | -0.04 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 146.43 | 97.89 | 137.79 | - | - | Upgrade
|
| Issuance of Common Stock | 126.68 | 21.34 | 8.2 | 50.72 | 617.76 | Upgrade
|
| Other Financing Activities | - | - | 415.83 | - | - | Upgrade
|
| Financing Cash Flow | 273.11 | 119.23 | 561.81 | 50.72 | 617.76 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.91 | 0.2 | -0.21 | -0.89 | -0.35 | Upgrade
|
| Net Cash Flow | 32.12 | -43.38 | -90.22 | -474.69 | 570.2 | Upgrade
|
| Free Cash Flow | -197.22 | -452.91 | -511.2 | -301.74 | 383.88 | Upgrade
|
| Free Cash Flow Margin | -38.76% | -181.61% | -250.54% | -167.56% | 48.36% | Upgrade
|
| Free Cash Flow Per Share | -3.14 | -7.48 | -8.57 | -5.16 | 6.83 | Upgrade
|
| Cash Interest Paid | 79.85 | 38.47 | 9.81 | - | - | Upgrade
|
| Cash Income Tax Paid | 1.1 | -0.05 | 6.51 | 0.69 | 0.78 | Upgrade
|
| Levered Free Cash Flow | -76.03 | -249 | -273.16 | -308.41 | 272.4 | Upgrade
|
| Unlevered Free Cash Flow | -33.03 | -216.75 | -262.06 | -308.41 | 272.4 | Upgrade
|
| Change in Net Working Capital | 21.07 | 1.1 | 27.9 | 2.2 | -0.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.